Home › Colon Cancer › Illinois › Evanston
Colon Cancer clinical trials in Evanston, IL
4 studies for Colon Cancer are looking for participants at sites in and around Evanston (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
RecruitingPhase 3
- Endeavor Health ( Site 2027), Evanston
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Illinois Cancer Specialists, Niles · 6 mi away
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RecruitingPhase 3
- Endeavor Health, Evanston
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
RecruitingPhase 2/3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · 5 mi away
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi away
- and 2 more
Colon Cancer trials in other cities
- Boston, MA22 studies
- New York City, NY22 studies
- Houston, TX20 studies
- Nashville, TN16 studies
- Los Angeles, CA16 studies
- Arlington, VA15 studies
- St. Louis, MO15 studies
- San Antonio, TX14 studies
- Tampa, FL13 studies
- Baldwin Park, CA13 studies
- Chicago, IL13 studies
- Baltimore, MD13 studies
Other studies in Evanston
- Non-Small Cell Lung Cancer22 studies
- Lung Cancer19 studies
- Breast Cancer13 studies
- Acute Myeloid Leukemia11 studies
- Obesity11 studies
- Cancer (all types)10 studies
- Crohn's Disease9 studies
- Ulcerative Colitis9 studies
- Overweight9 studies
- Prostate Cancer9 studies
- Colorectal Cancer9 studies
- Atrial Fibrillation8 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.